The present invention provides novel pyrimidine amines of formula (I) which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD and rheumatoid arthritis.
-
Page/Page column 260-261
(2011/07/07)
More Articles about upstream products of 1312537-06-6
Get Best Price for1312537-06-65-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-N-(2,2,2-trifluoroethyl)-N-4-[(trifluoromethyl)pyrimidin-2-yl]benzene-1,3-diamine